gut microbiota

Postbiotics, from bench to bedside

An open discussion about definition, clinical trial design and fields of application of postbiotics with Maria Rescigno, Professor at Humanitas University of Milan.

A mother’s vaginal microbes don’t influence her baby’s gut microbiota

The findings of a recent study show that a mother’s vaginal microbiota does not affect infant gut microbiota composition and development.

Nosocomial infection risks in critical illness: the microbiota-immune metasystem connection

An altered metasystem linking the gut microbiota and systemic immune response could lead to impaired host defense and increased vulnerability to hospital-acquired infections in cases of severe illness.

Targeting gut microbiome for disease diagnosis and therapy

Francesco Peri, full professor at University of Milano-Bicocca, discussed the role of gut microbiome as new frontier for personalized medicine.

Arresting microbiota development stunts immune system maturation in mice

A recent study shows that microbiota maturation during weaning contributes to normal immune development and protection from infection.

Epsilon toxin-producing Clostridium perfringens colonize the gut of multiple sclerosis patients

ETX-producing C. perfringens strains are biologically plausible pathogens in MS that trigger inflammatory demyelination.

Human gut bacteria produce Th17-modulating bile acid metabolites

During MicrobiotaMI congress we discussed with Jun Huh, Associate Professor at Harvard University, about the research on microbiome.

Mainz Biomed Partners with Microba Life Sciences for the Development of PancAlert

This partnership aims to leverage Microba's advanced technology platform for measuring the human gut microbiome to discover novel biomarkers for pancreatic cancer detection. 

Gut microbes sway how people with lymphoma respond to immunotherapy

The findings of a recent study identified microbiota signatures that may allow clinicians to predict the outcomes of CAR-T immunotherapy.

Gut bacteria Parabacteroides Distasonis: a new hope for the treatment of inflammatory arthritis

The findings of a recent study reveal that P. distasonis and its metabolites could be promising candidates for treating RA.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top